[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 129,168
  • Shares Outstanding, K 127,259
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,430 K
  • EBIT $ 0 M
  • EBITDA $ -21 M
  • 60-Month Beta 0.46
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 687.64% (+74.30%)
  • Historical Volatility 74.73%
  • IV Percentile 95%
  • IV Rank 50.44%
  • IV High 1,320.09% on 09/10/25
  • IV Low 43.89% on 03/17/26
  • Expected Move (DTE 31) 0.0765 (7.65%)
  • Put/Call Vol Ratio 0.52
  • Today's Volume 320
  • Volume Avg (30-Day) 115
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 2,763
  • Open Int (30-Day) 2,370
  • Expected Range 0.9235 to 1.0765

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9105 +9.83%
on 07/21/26
1.4700 -31.97%
on 07/14/26
-0.1600 (-13.79%)
since 06/18/26
3-Month
0.9105 +9.83%
on 07/21/26
1.8500 -45.95%
on 05/21/26
-0.2300 (-18.70%)
since 04/21/26
52-Week
0.9105 +9.83%
on 07/21/26
2.6000 -61.54%
on 08/01/25
-0.6200 (-38.27%)
since 07/21/25

Most Recent Stories

More News
RIVN Stock Pops as Rivian Raises Delivery Outlook

Rivian stock rallies on better-than-expected Q2 deliveries and raised full-year outlook. Canaccord reiterated its bullish view on RIVN shares today.

TLSA : 1.0000 (-1.48%)
RIVN : 17.76 (+3.02%)
Aquestive Therapeutics Announces Leadership Expansion to Support Growth

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company’s ongoing development initiatives  ...

TLSA : 1.0000 (-1.48%)
AQST : 4.04 (+2.41%)
Tiziana Life Sciences Reports Interim Results and Expands U.S. Presence

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Tiziana Life...

TLSA : 1.0000 (-1.48%)
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week

New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025.

TLSA : 1.0000 (-1.48%)
AIM : 0.2490 (-0.40%)
PEPG : 2.12 (-3.64%)
AEON : 0.2880 (-0.35%)
MBRX : 2.15 (+0.47%)
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis

Tiziana Life Sciences expands Phase 2 trial for intranasal foralumab in non-active secondary progressive multiple sclerosis across prominent Northeast institutions.Quiver AI SummaryTiziana Life Sciences,...

TLSA : 1.0000 (-1.48%)
Tiziana Life Sciences Receives ALS Association Grant to Advance Clinical Trial of Intranasal Foralumab for ALS Treatment

Tiziana Life Sciences receives funding from the ALS Association for a clinical trial of intranasal foralumab in ALS patients.Quiver AI SummaryTiziana Life Sciences, a biotechnology company focused on immunomodulation...

TLSA : 1.0000 (-1.48%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END

TGTX : 53.95 (-0.02%)
TLSA : 1.0000 (-1.48%)
LLY : 1,175.41 (+2.49%)
RHHBY : 51.1400 (+0.27%)
BIIB : 203.16 (+1.61%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

TGTX : 53.95 (-0.02%)
TLSA : 1.0000 (-1.48%)
LLY : 1,175.41 (+2.49%)
RHHBY : 51.1400 (+0.27%)
BIIB : 203.16 (+1.61%)

Business Summary

Tiziana Life Sciences PLC is a biotechnology company. It focuses on the clinical development for the treatment of cancers, chronic inflammatory and autoimmune neurodegenerative disorders. The company's product pipeline consists of Foralumab TZLS-401 and Milciclib TZLS-201 which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 1.1860
2nd Resistance Point 1.1130
1st Resistance Point 1.0565
Last Price 1.0000
1st Support Level 0.9270
2nd Support Level 0.8540
3rd Support Level 0.7975

See More

52-Week High 2.6000
Fibonacci 61.8% 1.9546
Fibonacci 50% 1.7552
Fibonacci 38.2% 1.5559
Last Price 1.0000
52-Week Low 0.9105

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.